UD
The startup develops rapid diagnostic tests that utilize blood biomarkers to accurately identify large vessel occlusion strokes within minutes using a single-drop blood sample. This technology enables emergency medical professionals to provide timely diagnoses, improving patient outcomes and reducing healthcare costs.
Updated 18 months ago
Funding
$2.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops rapid diagnostic tests that utilize blood biomarkers to accurately identify large vessel occlusion strokes within minutes using a single-drop blood sample. This technology enables emergency medical professionals to provide timely diagnoses, improving patient outcomes and reducing healthcare costs.